AutoCRAT is a Horizon 2020 Project focused on:
delivering new cell and cell-based therapies for osteoarthritis (OA) and joint repair using sustainable sources of cells and
developing a closed, scalable and regulatory-compliant automated system to enable future production of therapeutic products.
Repairing Damage
Repairing Damage
AutoCRAT will explore using articular chondrocytes (cartilage cells) to help repair damage to joints.
Preventing & Treating OA
Preventing & Treating OA
AutoCRAT will explore using mesenchymal stromal cells (MSC) and extracellular vesicles (EVs) to prevent and to treat OA.Generating Cells
Generating Cells
AutoCRAT will generate sustainable sources of cells ready for therapeutic use.
Automated Production
Automated Production
AutoCRAT will build a Regenerative Medicine Factory for cost-effective, controlled, automated manufacture of therapeutic products in line with regulations.
The AutoCRAT Team
The AutoCRAT consortium is made up of the following partners:
Find out more about the Team here.
Latest News
Read all about our news, project updates and announcements on our news page.
NUI Galway hosts cell and EV imaging webinar, December 10, 2020
Join AutoCRAT partners at NUI Galway as they host the webinar “Real-Time Near Infrared Fluorescence Imaging Research Tools With The Potential For Clinical Use” on December 10, 2020, at 2 pm GMT. Click here for [...]
AutoCRAT acknowledged by Prof Dr Bernd Giebel at ISLB conference
Prof Dr Bernd Giebel, University Hospital Essen At the virtual International Society of Liquid Biopsy (ISLB) conference on Friday, October 30th, 2020, Prof Dr Bernd Giebel of the University Medicine Essen (www.uk-essen.de) will [...]
Partner news: Valitacell selected for the Startup Creasphere health tech accelerator programme
Dr Stephanie Davies leads Valitacell’s team in AutoCRAT AutoCRAT partners, Valitacell, (www.valitacell.com) a Dublin-headquartered biotechnology SME, has been selected by as one of eleven high potential global start-ups to join the prestigious health [...]